Trigger Point Pain, MyofascialNCT05925855
Effect of Phonophoresis on Trigger Points
A study testing US with fastum, US with reparil and US with plain gel in people with Trigger Point Pain, Myofascial, run by Batterjee Medical College at 1 site in Saudi Arabia.
Trial summary
purpose of this study was to investigate the effects of phonophoresis with fastum gel versus reparil gel on pain intensity, pain threshold, and cervical ROM of participant with trigger point of upper trapezius. Read more about this study
- Who is it for?
- Ages 18 to 35 years
- Conditions the study is for
- Trigger Point Pain, Myofascial
- What is being tested?
- US with fastum, US with reparil and US with plain gel
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 66 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 1 Jul 2023to 30 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- upper trapezius trigger point
Who cannot join
- cervical disc
Trial locations and contacts
1 site in 1 country.
About this study
purpose of this study was to investigate the effects of phonophoresis with fastum gel versus reparil gel on pain intensity, pain threshold, and cervical ROM of participant with trigger point of upper trapezius.
Read the detailed description
participants will be divided into 3 groups, 2 study groups and 1 control group.
- Conditions
- Trigger Point Pain, Myofascial
- Being tested
- US with fastum, US with reparil, US with plain gel
- Medical subject headings
- Myofascial Pain Syndromes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
US with fastumOther
apply fastum on trigger point with US
US with reparilOther
apply reparil on trigger point with US
US with plain gelOther
apply gel on trigger point with US
| Study group | Role | What they receive |
|---|---|---|
| study Fastum | Experimental | participant in this group will receive US with fastum gel Receives: Other: US with fastum |
| study Reparil | Experimental | participant in this group will receive US with reparil gel Receives: Other: US with reparil |
| Control plain gel | Active comparator | participant in this group will receive US with gel Receives: Other: US with plain gel |
What is being measured
The primary outcome is the main question the study is designed to answer.
pain intensity
change of pain intensity by using VAS from 0 to 10
Measured: Two weeks and 3 months follow up
pain threshold
change of pain threshold by using PPA
Measured: two weeks and 3 months follow up
ROM
change of ROM by using CROM
Measured: two weeks and 3 months follow up
neck function
change of neck function by using Neck Disability Index (NDI) questionnaire
Measured: Two weeks and 3 months follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jun 2023
- Study start1 Jul 2023
- Primary completion1 Aug 2023
- Study completion30 Dec 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Trigger Point Pain, MyofascialStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 66 participants (actual)
Sponsor and investigators
- Lead sponsor
- Batterjee Medical College
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Reem Dawood, Batterjee Medical College
- Investigators
- Osama R Abdelraouf, PhD, Study director, Batterjee Medical College
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05925855
- Sponsor's protocol ID
- Phonophoresis
- Status last verified
- Jul 2023
- First submitted
- 13 Jun 2023
- Last updated
- 1 Oct 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: all data are secured with principle investigator.
Study at a glance
From the registry record, last updated by the sponsor on 1 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Phonophoresis on Trigger Points
- ClinicalTrials.gov ID
- NCT05925855
- Acronym / sponsor ID
- Phonophoresis
- Conditions
- Trigger Point Pain, Myofascial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 66 participants (actual)
- Lead sponsor
- Batterjee Medical CollegeUniversity, hospital or other
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 1 Aug 2023 (actual)
- Study completion
- 30 Dec 2023 (actual)
- First posted
- 29 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
purpose of this study was to investigate the effects of phonophoresis with fastum gel versus reparil gel on pain intensity, pain threshold, and cervical ROM of participant with trigger point of upper trapezius.
Detailed description
participants will be divided into 3 groups, 2 study groups and 1 control group.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| study Fastum | Experimental | Other: US with fastumparticipant in this group will receive US with fastum gel |
| study Reparil | Experimental | Other: US with reparilparticipant in this group will receive US with reparil gel |
| Control plain gel | Active comparator | Other: US with plain gelparticipant in this group will receive US with gel |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- upper trapezius trigger point
Key exclusion criteria (1 listed)
- cervical disc
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| US with fastumapply fastum on trigger point with US | Other | study Fastum |
| US with reparilapply reparil on trigger point with US | Other | study Reparil |
| US with plain gelapply gel on trigger point with US | Other | Control plain gel |
Primary outcome
pain intensity
Time frame: Two weeks and 3 months follow up
change of pain intensity by using VAS from 0 to 10
pain threshold
Time frame: two weeks and 3 months follow up
change of pain threshold by using PPA
ROM
Time frame: two weeks and 3 months follow up
change of ROM by using CROM
neck function
Time frame: Two weeks and 3 months follow up
change of neck function by using Neck Disability Index (NDI) questionnaire
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Oct 2026.
- Individual participant dataSharing planned: No. all data are secured with principle investigator.
Related trials for Trigger Point Pain, Myofascial
Recruiting
Evaluation of the Effect of Adding Sodium Bicarbonate to Lidocaine in the Treatment of Myofascial Pain Syndrome
Myofacial Pain, Myofacial Pain Syndrome
Not yet recruiting
Focused Versus Multi-Target Trigger Point Injection for Chronic Myofascial Neck Pain
Myofacial Pain Syndrome, Chronic Neck Pain
Recruiting
Comparing Myofascial Exercise and Trigger Point Therapy for Non-Specific Low Back Pain
Non-specific Low Back Pain
Not yet recruitingPhase 4
Botulinum Toxin Type A Versus Triamcinolone for Facial Myalgia
Myofascial Pain Syndrome (MPS)
Not yet recruiting
Comparison of Suboccipital Release and Muscle Energy Technique in Subjects With Mechanical Neck Pain and Forward Head Posture
Myofascial Trigger Points, Neck Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Osama R Abdelraouf, PhD study director
Batterjee Medical College
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing US with fastum, US with reparil and US with plain gel in people with Trigger Point Pain, Myofascial, run by Batterjee Medical College at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
pain intensity (time frame: Two weeks and 3 months follow up). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026.